PQNT0.620%
as of Jul 21
4519
GrowthCHUGAI PHARMACEUTICAL CO /JPY/
Close · 3M
-19.46%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals1
Win rate0% (0/1)
Avg buy return0.00%
PQNT · Weight increase · 2d
CHUGAI PHARMACEUTICAL CO's recent performance shows a 30-day return of -11.3% and a 1-year return of -19.5%, placing its $45.10 current price near the lower end of its 52-week range at $44.53. This decline, bringing the stock to 81% of its 52-week high, suggests that PQNT's AI signals, combined with its factor exposures for valuation and sentiment, identified a potential entry point for this Health Care sector stock within its ex-US developed-market universe. The observed consecutive weight increases for CHUGAI in PQNT, specifically from 0.60% on July 17 to 0.62% on July 19, coincide with the stock trading just above its 52-week low, indicating the fund's models likely detected a favorable risk/reward scenario after a prolonged downward trend. Pictet Asset Management's AI overlay on PQNT, a newer fund launched in 2025, appears to have leveraged this significant price correction in CHUGAI, a Japanese pharmaceutical company, as a prime opportunity based on its multi-factor analysis, despite the negative short and long-term momentum.
weight 0.600% → 0.620% (+0.020 pp)·stock down 4.3% in the 30 days before
Jul 19·entry 45.10·now 45.10Fresh
0.00%
since Jul 19
PQNT · Weight decrease · 2d
PQNT, managed by Pictet Asset Management, integrates AI signals with factor exposures, including fundamentals, momentum, valuation, and sentiment, across its portfolio of approximately 300 international developed-market stocks. The consecutive weight decrease for CHUGAI PHARMACEUTICAL CO, moving from 0.70% to 0.64% between June 12 and June 15, suggests the fund's AI models identified a deterioration in specific factor conditions for the Health Care company during a periodic rebalancing window. This downward adjustment reflects the AI's response to the stock's recent market dynamics, notably its -17.0% 90-day return, indicating that momentum or sentiment factors registered a decline. The fund’s AI overlay thus specifically de-risked exposure to 4519 based on its comprehensive data analysis.
weight 0.700% → 0.640% (-0.060 pp)·stock down 8.2% in the 30 days before
Jun 15·entry 46.50·now 45.10
-3.00%
since Jun 15
PQNT · Weight decrease · 2d
weight 0.690% → 0.650% (-0.040 pp)·stock down 11.8% in the 30 days before
Jun 4·entry 46.41·now 45.10
-2.82%
since Jun 4
PQNT · Weight decrease · 2d
Trading near its recent lows in late May 2026, CHUGAI PHARMACEUTICAL CO (4519) likely presented a negative momentum signal to PQNT's AI-driven system. This recent price trajectory, alongside other potentially shifting factor exposures such as sentiment or valuation, informed Pictet Asset Management's AI overlay, which combines these elements for its ex-US developed-market portfolio. Consequently, the fund executed a consecutive weight decrease for the Health Care company from 0.74% on May 27 to 0.68% by May 30, a direct result of the model's periodic rebalancing based on an updated risk/reward assessment. This specific adjustment by the newer 2025-launched fund highlights the AI's role in dynamically adjusting exposure to individual stocks like CHUGAI, moving away when its combined signals indicate a less appealing investment profile.
weight 0.740% → 0.680% (-0.060 pp)·stock down 0.3% in the 30 days before
May 30·entry 49.58·now 45.10
-9.03%
since May 30
PQNT · Weight decrease · 3d
The AI ETF likely reduced its Chugai Pharmaceutical weight due to detected sustained negative signals, such as deteriorating fundamental metrics, adverse technical indicators, or a shift in market sentiment. For retail investors, this persistent decrease indicates the AI's model has identified ongoing concerns, prompting a need to independently research recent company news or sector developments for potential underlying issues.
weight 0.770% → 0.730% (-0.040 pp)
May 10·entry 50.44·now 45.10
-10.58%
since May 10
PQNT · Weight decrease · 2d
The AI ETF likely initiated consecutive weight decreases for Chugai Pharmaceutical due to its algorithms identifying deteriorating fundamental outlooks, negative sentiment indicators, or a shift in the company's risk profile within the healthcare sector. This proactive de-risking suggests the AI anticipates potential underperformance or increased headwinds for the stock. Retail investors should interpret this as a prompt to conduct independent research into recent company news, sector trends, or earnings reports before making any investment decisions.
weight 0.770% → 0.750% (-0.020 pp)
May 8·entry 50.44·now 45.10
-10.58%
since May 8
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.